Cargando…
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
BACKGROUND: In Sudan, chloroquine (CQ) remains the most frequently used drug for falciparum malaria for more than 40 years. The change to artemisinin-based combination therapy (ACT) was initiated in 2004 using the co-blister of artesunate + sulfadoxine/pyrimethamine (AS+SP) and artemether + lumefant...
Autores principales: | Malik, EM, Mohamed, TA, Elmardi, KA, Mowien, RM, Elhassan, AH, Elamin, SB, Mannan, AA, Ahmed, ES |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590042/ https://www.ncbi.nlm.nih.gov/pubmed/16879742 http://dx.doi.org/10.1186/1475-2875-5-65 |
Ejemplares similares
-
Immunological Characteristics of Hyperreactive Malarial Splenomegaly Syndrome in Sudanese Patients
por: Alkadarou, Tayseer, et al.
Publicado: (2013) -
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
por: Daher, André, et al.
Publicado: (2019) -
Thyroid Function/Antibodies in Sudanese Patients with Preeclampsia
por: Elhaj, Enaam T., et al.
Publicado: (2015) -
Do frontline health care providers know enough about artemisinin–based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan
por: Mannan, Abeer A, et al.
Publicado: (2015) -
Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test
por: Elmardi, Khalid A, et al.
Publicado: (2009)